Viatris Asks FDA Not To Approve Neffy Until Sponsor Conducts More PK/PD Studies

EpiPen maker says available evidence does not answer questions about how an intranasal epinephrine from ARS Pharmaceuticals will perform in a real-world anaphylaxis event. Viatris citizen petition argues issues raised at advisory committee were not resolved.